Clinical Trial Update: Etanercept for the Treatment of Chronic Urticaria [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of etanercept for chronic idiopathic urticaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: University of Utah | Conditions: Chronic Idiopathic Urticaria | Phase 2, Phase 3 | Status: WITHDRAWN